StonvexLoading…
StonvexStonvexStonvexCore line items from SF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.77B | $3.29B | $2.71B | $2.95B |
Operating Income | $871.14M | $928.44M | $706.69M | $885.12M |
Net Income | $683.78M | $731.38M | $522.54M | $662.15M |
EPS (Diluted) | $5.87 | $6.25 | $4.28 | $5.32 |
Total Assets | $41.27B | $39.90B | $37.73B | $37.20B |
Total Liabilities | $35.29B | $34.21B | $32.43B | $31.87B |
Cash & Equivalents | $2.25B | $2.65B | $3.36B | $2.20B |
Free Cash Flow OCF − CapEx | $1.05B | $416.65M | $447.35M | $1.08B |
Shares Outstanding | 110.05M | 110.97M | 113.45M | 117.54M |